Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-08
2010-02-09
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252050, C514S255050, C514S256000, C514S292000, C514S326000, C514S333000, C514S341000, C514S364000, C514S365000, C514S383000, C514S397000, C544S124000, C544S238000, C544S333000, C544S405000, C546S210000, C546S256000, C546S274100, C548S133000, C548S146000, C548S265200, C548S314700
Reexamination Certificate
active
07659270
ABSTRACT:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
REFERENCES:
patent: 5654451 (1997-08-01), Kari
patent: 2004/0142985 (2004-07-01), Singh et al.
patent: 2005/0119318 (2005-06-01), Hudyma et al.
patent: WO 94/15909 (1994-07-01), None
patent: WO 2004/002940 (2004-01-01), None
patent: WO 2005/047288 (2005-05-01), None
patent: WO 2005/105761 (2005-11-01), None
patent: WO 2006/022442 (2006-03-01), None
patent: WO 2006/093867 (2006-09-01), None
patent: WO 2006/133326 (2006-12-01), None
patent: WO 2007/031791 (2007-03-01), None
patent: WO 2007/058384 (2007-05-01), None
patent: WO 2007/077186 (2007-07-01), None
patent: WO 2007/080401 (2007-07-01), None
patent: WO 2007/081517 (2007-07-01), None
patent: WO 2007/082554 (2007-07-01), None
patent: WO2007/138242 (2007-12-01), None
patent: WO2008/021927 (2008-02-01), None
patent: WO2008/021936 (2008-02-01), None
U.S. Appl. No. 12/120,494, filed May 14, 2008, Bachand, et al.
U.S. Appl. No. 12/030,232, filed Feb. 13, 2008, Bachand, et al.
U.S. Appl. No. 12/029,680, filed Feb. 12, 2008, Bachand et al.
Bachand Carol
Belema Makonen
Deon Daniel H.
Good Andrew C.
Goodrich Jason
Bristol--Myers Squibb Company
Chu Yong
Mingo Pamela A.
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179450